Sanofi Consumer Healthcare India

SANOFICONR.NS

Drug Manufacturers - General · Healthcare

Exchange

National Stock Exchange of India

Winston Score

Winston is happy

A high-quality business with solid fundamentals.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Exceptional

Growth

Exceptional

Cash Flow

Good

Stability

Exceptional

Valuation

Weak

Dividends

Weak

Track this stock — start free trial

Winston Score History

The full picture

Sanofi Consumer Healthcare India Ltd. sells over-the-counter health products directly to everyday consumers in India. Its core brands include well-known products in vitamins, minerals, supplements, and digestive health — such as Combiflam (a pain reliever) and Allegra (an allergy medicine). The company is part of the global Sanofi group, one of the largest pharmaceutical companies in the world.

The company makes money by selling branded consumer health products through pharmacies, retail stores, and online channels across India. Its high gross margin reflects the pricing power that comes from owning trusted, recognizable brand names — a key competitive advantage in the Indian consumer health market. The main growth driver is India's expanding middle class and rising health awareness, which is increasing demand for self-care products. The main risk is competition from both large multinational brands and lower-cost local generic manufacturers eating into market share.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+6.7% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+13.5% YoY

YoY Growth Rate

Steady EPS growth

Insider Activity

71.5%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

₹4.9B cash & investments

Quarterly Free Cash Flow

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Sanofi Consumer Healthcare India is growing revenue at 7% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

61.4%

Premium pricing power — 61.4% gross margin

Profit after running costs

Operating Margin

36.5%

Excellent — 36.5% operating margin

Return on the money invested

ROCE

95.4%

Exceptional — 95.4% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+29.4%

Fast-growing sales (+29.4% YoY)

Profit growth

EPS YoY

+33.1%

Earnings growing fast (+33.1% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is

EPS Consistency

4/4 quarters

Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

66%

Modest — 66% of profit becomes cash

Spare cash per sale

FCF Margin

17.6%

Converts sales into free cash efficiently (17.6%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.02

Conservative — low debt load (0.02)

Covers its interest

Interest Cover

169.85x

Comfortably covers interest (169.8x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

36.5x

no trend

Pricey — P/E 36.5

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year

P/E vs Forward

-1.1

SLOWING

Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

1.65%

no trend

Small dividend — 1.65% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record

Dividend Growth

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial